PURE Bioscience, Inc. (PURE) Reports Q4 Loss of $0.05
PURE Bioscience, Inc. (NASDAQ: PURE) reported Q4 EPS of ($0.05), versus ($0.05) reported last year. Revenue for the quarter came in at $244 thousand, versus $324 thousand reported last year.